Olivo Alicia C forfeited 2,692 Neogenomics shares on September 1, 2026, leaving her with 90,875 shares. The transaction gives investors a precise view of the executive’s reported post-transaction ownership and identifies the change as a forfeiture under transaction code F.
Key Highlights
- Olivo Alicia C held 90,875 Neogenomics shares after the transaction.
- The transaction occurred on September 1, 2026.
- The transaction used code F and involved Olivo Alicia C, Neogenomics’ EVP, GC & Business Development.
Olivo Alicia C forfeited 2,692 shares of Neogenomics Inc. on September 1, 2026, leaving her with 90,875 shares after the transaction. The reported change concerns the holdings of the company’s EVP, GC & Business Development. The transaction involved Neogenomics Inc. and was recorded under transaction code F. Olivo Alicia C’s position following the transaction was 90,875 shares. The reported forfeiture covered 2,692 shares. The transaction date was September 1, 2026.
Neogenomics Executive Holding After Share Forfeiture
Olivo Alicia C’s post-transaction ownership was 90,875 shares. The transaction affected 2,692 shares. Her role at Neogenomics Inc. is EVP, GC & Business Development. The transaction was identified with code F. The reported information records the executive’s ownership position after the forfeiture.
FAQs
Q: What happened to Olivo Alicia C’s Neogenomics shares?
A: Olivo Alicia C forfeited 2,692 Neogenomics shares on September 1, 2026. Her reported ownership after the transaction was 90,875 shares.
Q: How many Neogenomics shares does Olivo Alicia C own after the transaction?
A: Following the filing, Olivo Alicia C owned 90,875 Neogenomics shares. The reported transaction was a forfeiture of 2,692 shares, recorded on September 1, 2026.
Q: What was Olivo Alicia C’s role at Neogenomics?
A: Olivo Alicia C served as Neogenomics Inc.’s EVP, GC & Business Development. Her share transaction was recorded under code F on September 1, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.